Klebsiella pneumoniae peptidoglycan-associated lipoprotein and murein lipoprotein contribute to serum resistance, antiphagocytosis, and proinflammatory cytokine stimulation

Journal of Infectious Diseases

Volumn 208, Issue 10, 2013, Pages 1580-1589

  Hsieh, Pei Fang ^a   Liu, Ju Yun ^a,b   Pan, Yi Jiun ^a   Wu, Meng Chuan ^b   Lin, Tzu Lung ^a   Huang, Yen Te ^b   Wang, Jin Town ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Klebsiella pneumoniae; Murein lipoprotein; Outer membrane protein a; Outer membrane proteins; Peptidoglycan associated lipoprotein

Indexed keywords

BILE SALT; CEFOTAXIME; CIPROFLOXACIN; COLISTIN; DETERGENT; DODECYL SULFATE SODIUM; GENTAMICIN; IMMUNOGLOBULIN G; INTERLEUKIN 6; MUREIN LIPOPROTEIN; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN A; PEPTIDOGLYCAN ASSOCIATED LIPOPROTEIN; POLYMYXIN B; POLYPEPTIDE ANTIBIOTIC AGENT; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; FEMALE; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION PREVENTION; INFECTION RESISTANCE; INNATE IMMUNITY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PATHOGENESIS; PERMEABILITY BARRIER; PHAGOCYTOSIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; WILD TYPE;

KLEBSIELLA PNEUMONIAE; MUREIN LIPOPROTEIN; OUTER MEMBRANE PROTEIN A; OUTER MEMBRANE PROTEINS; PEPTIDOGLYCAN-ASSOCIATED LIPOPROTEIN;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; CELL MEMBRANE PERMEABILITY; CYTOKINES; DETERGENTS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION MEDIATORS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICE; MICROBIAL SENSITIVITY TESTS; MUTATION; NEUTROPHILS; PEPTIDOGLYCAN; PHAGOCYTOSIS; PHENOTYPE; VIRULENCE;

EID: 84888612488     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit384     Document Type: Article

References (28)

1. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998; 11:589-603.
2. Ramphal R, Ambrose PG. Extended-spectrum beta-lactamases and clinical outcomes: current data. Clin Infect Dis 2006; 42(suppl 4): S164-72.
3. Ko WC, Paterson DL, Sagnimeni AJ, et al. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis 2002; 8:160-6.
4. Tsai FC, Huang YT, Chang LY, Wang JT. Pyogenic liver abscess as endemic disease, Taiwan. Emerg Infect Dis 2008; 14:1592-600.
5. Cortes G, Borrell N, de Astorza B, Gomez C, Sauleda J, Alberti S. Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect Immun 2002; 70:2583-90.
6. Shankar-Sinha S, Valencia GA, Janes BK, et al. The Klebsiella pneumoniae O antigen contributes to bacteremia and lethality during murine pneumonia. Infect Immun 2004; 72:1423-30.
7. Lugo JZ, Price S, Miller JE, et al. Lipopolysaccharide O-antigen promotes persistent murine bacteremia. Shock 2007; 27:186-91.
8. Fang CT, Chuang YP, Shun CT, Chang SC, Wang JT. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J Exp Med 2004; 199:697-705.
9. Hsieh PF, Lin TL, Yang FL, et al. Lipopolysaccharide O1 antigen contributes to the virulence in Klebsiella pneumoniae causing pyogenic liver abscess. PLoS One 2012; 7:e33155.
10. Hofstra H, Dankert J. Major outer membrane proteins: common antigens in Enterobacteriaceae species. J Gen Microbiol 1980; 119:123-31.
11. Hellman J, Warren HS. Outer membrane protein A (OmpA), peptidoglycan- Associated lipoprotein (PAL), and murein lipoprotein (MLP) are released in experimental gram-negative sepsis. J Endotoxin Res 2001; 7:69-72.
12. Hsieh PF, Lin TL, Lee CZ, Tsai SF, Wang JT. Serum-induced iron-acquisition systems and TonB contribute to virulence in Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis 2008; 197:1717-27.
13. Hsieh PF, Lin HH, Lin TL, Wang JT. CadC regulates cad and tdc operons in response to gastrointestinal stresses and enhances intestinal colonization of Klebsiella pneumoniae. J Infect Dis 2010; 202:52-64.
14. Chuang YP, Fang CT, Lai SY, Chang SC, Wang JT. Genetic determinants of capsular serotype K1 of Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis 2006; 193:645-54.
15. Tsai CM, Frasch CE. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem 1982; 119:115-9.
16. Domenico P, Schwartz S, Cunha BA. Reduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate. Infect Immun 1989; 57:3778-82.
17. Pan YJ, Lin TL, Hsu CR, Wang JT. Use of a Dictyostelium model for isolation of genetic loci associated with phagocytosis and virulence in Klebsiella pneumoniae. Infect Immun 2011; 79:997-1006.
18. EUCAST Definitive Document E. DEF 3.1, June 2000: Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clin Microbiol Infect 2000; 6:509-15.
19. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27:493-7.
20. Merino S, Camprubi S, Alberti S, Benedi VJ, Tomas JM. Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing. Infect Immun 1992; 60:2529-35.
21. Gunn JS. Mechanisms of bacterial resistance and response to bile. Microbes Infect 2000; 2:907-13.
22. Liang MD, Bagchi A, Warren HS, et al. Bacterial peptidoglycan-associated lipoprotein: A naturally occurring Toll-like receptor 2 agonist that is shed into serum and has synergy with lipopolysaccharide. J Infect Dis 2005; 191:939-48.
23. Zhang H, Peterson JW, Niesel DW, Klimpel GR. Bacterial lipoprotein and lipopolysaccharide act synergistically to induce lethal shock and proinflammatory cytokine production. J Immunol 1997; 159:4868-78.
24. Lo YY, Hsu SH, Ko YC, et al. Essential calcium-binding cluster of Leptospira LipL32 protein for inflammatory responses through the Tolllike receptor 2 pathway. J Biol Chem 2013; 288:12335-44.
25. Hellman J, Tehan MM, Warren HS. Murein lipoprotein, peptidoglycan- Associated lipoprotein, and outer membrane protein A are present in purified rough and smooth lipopolysaccharides. J Infect Dis 2003; 188:286-9.
26. Hellman J, Roberts JD Jr, Tehan MM, Allaire JE, Warren HS. Bacterial peptidoglycan-associated lipoprotein is released into the bloodstream in gram-negative sepsis and causes inflammation and death in mice. J Biol Chem 2002; 277:14274-80.
27. Sha J, Fadl AA, Klimpel GR, Niesel DW, Popov VL, Chopra AK. The two murein lipoproteins of Salmonella enterica serovar Typhimurium contribute to the virulence of the organism. Infect Immun 2004; 72:3987-4003.
28. Valentine CH, Hellman J, Beasley-Topliffe LK, Bagchi A, Warren HS. Passive immunization to outer membrane proteins MLP and PAL does not protect mice from sepsis. Mol Med 2006; 12:252-8.